SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is trending as a high-volatility short squeeze play, with traders closely monitoring its exceptionally low float and rising borrow rates that are forcing shorts to cover positions. The community is actively debating the stock's potential to reach triple-digit prices, while balancing excitement for parabolic gains against warnings of impending dilution and the risks of a sharp reversal.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is currently trending as investors weigh strong earnings beats and positive long-term product milestones against concerns over shareholder dilution and a large executive compensation package. The community is sharply divided between bulls focusing on the production ramp of the R2 SUV and bears warning about ongoing cash burn and the potential for capital raises.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox stock is facing significant volatility following a sharp post-earnings sell-off, with investors expressing intense polarization over the company's growth deceleration, mounting regulatory and child-safety concerns, and the long-term viability of its engagement metrics. While some community members see the depressed valuation as a deep-value buying opportunity for a long-term recovery, others are actively shorting the stock, citing management's guidance cuts and persistent structural challenges as signs of a weakening platform.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors react to a powerful earnings report that showcased record cloud revenue growth and robust AI integration, driving shares to all-time highs. The market is currently fixated on whether the company's aggressive AI infrastructure spending will continue to translate into sustainable, high-margin revenue growth compared to its mega-cap peers.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors weigh strong earnings growth and a potential buyout, driven by the company's transition to profitability and the successful commercialization of Miplyffa. The community is heavily focused on the high concentration of former Genzyme and Sanofi executives at Zevra, which many believe makes the company a natural acquisition target for Sanofi under its new leadership.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending following a significant earnings beat and positive guidance, which has fueled a sharp post-market rally and helped catalyze a broader recovery in sentiment for the enterprise software sector. The community is actively debating whether this performance marks a sustainable turnaround for SaaS companies or a temporary relief rally amid ongoing concerns about AI-driven disruption.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is seeing significant social media buzz driven by a blowout earnings report that shattered analyst expectations for revenue and user growth. Community discussion is heavily focused on the stock's potential for a short squeeze, with many users highlighting strong monetization trends and the platform's unique value in the AI data licensing space.

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Edesa Biotech Inc

Edesa Biotech is experiencing significant volatility and trading volume as investors closely watch its low-float structure and potential for a strategic partnership or buyout ahead of upcoming medical conference presentations. The community is actively debating the stock's clinical prospects and high institutional ownership, with many monitoring for possible updates on regulatory pathways or non-dilutive funding that could impact its momentum.

Tidal Trust II - Defiance Daily Target 2X Short ASTS ETF

ASTN is seeing significant investor attention as traders utilize the 2X short ETF to hedge against or bet against the volatility of ASTS. The community remains deeply divided, with discussions centered on the ETF's performance relative to the underlying stock and concerns regarding the platform's handling of the bearish narrative.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending as investors weigh significant multi-billion dollar AI infrastructure expansion deals in India against ongoing concerns regarding management's communication and the lack of updated financial guidance. The community remains deeply divided, with bulls pointing to the company's technical pipeline and growth potential, while skeptics emphasize execution risks, valuation transparency, and previous periods of volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ProKidney (NASDAQ:PROK) Upgraded to Sell at Wall Street Zen

Wall Street Zen upgraded ProKidney from a "strong sell" rating to a "sell" rating in a research report on Saturday...

ProKidney (NASDAQ:PROK) Stock Price Up 9% - Should You Buy?

ProKidney (NASDAQ:PROK) Trading 9% Higher - Here's What Happened...

ProKidney Corp. (NASDAQ:PROK) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of ProKidney Corp. (NASDAQ:PROK - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight research firms that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has issued a...

ProKidney (NASDAQ:PROK) Sees Strong Trading Volume  - Time to Buy?

ProKidney (NASDAQ:PROK) Sees Strong Trading Volume - What's Next...

Hennion & Walsh Asset Management Inc. Has $3.37 Million Holdings in ProKidney Corp. $PROK

Hennion & Walsh Asset Management Inc. lifted its stake in shares of ProKidney Corp. (NASDAQ:PROK - Free Report) by 63.5% in the 4th quarter, according to its most recent Form 13F filing with the...

ProKidney (NASDAQ:PROK) Shares Up 5.9%  - Here's Why

ProKidney (NASDAQ:PROK) Trading 5.9% Higher - What's Next...

ProKidney (NASDAQ:PROK) Trading Down 7.6% - Here's What Happened

ProKidney (NASDAQ:PROK) Stock Price Down 7.6% - Should You Sell...

Q2 Earnings Forecast for ProKidney Issued By HC Wainwright

ProKidney Corp. (NASDAQ:PROK - Free Report) - Stock analysts at HC Wainwright issued their Q2 2026 earnings per share (EPS) estimates for shares of ProKidney in a research note issued on Thursday, March 19th. HC Wainwright analyst J. Pantginis expects that the company will post earnings per share of...

ProKidney Corp. (NASDAQ:PROK) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of ProKidney Corp. (NASDAQ:PROK - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eight ratings firms that are presently covering the firm, MarketBeat reports. Two...

ProKidney (NASDAQ:PROK) Cut to Sell at Wall Street Zen

Wall Street Zen cut ProKidney from a "hold" rating to a "sell" rating in a research note on Saturday...

ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.

PROK
ProKidney Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PROK News

PROKProKidney Corp